Managing Second-Line Antiretroviral Failure and Beyond: Evolving Strategies for Success

Register now for this complimentary CME-certified symposium presented preceding the IDWeek™ 2019.

In this highly interactive program, learn about the latest data on managing HIV in patients experiencing treatment failure beyond first-line ART. A panel of faculty will provide a case-based illustration of the key challenges and considerations when selecting new regimens after failure of second-line and later lines of therapy and will discuss and debate practical strategies for optimizing patient outcomes in such settings.


7:00 AM – 7:30 AM Breakfast and Registration

7:30 AM – 7:35 AM Welcome and Introduction

7:35 AM – 7:55 AM Evaluating and Managing HIV in Treatment-Experienced Patients - Paul E. Sax, MD

7:55 AM – 8:25 AM Expert Guidance on Selecting the Next Line of Therapy: Case-Based Discussion - Joseph J. Eron, Jr., MD; Paul E. Sax, MD

8:25 AM – 8:40 AM Question and Answer Session

8:40 AM – 8:45 AM Conclusions and Closing Thoughts


Date / Time
Event Details


Program Director
Paul Sax, MD

Clinical Director
HIV Program and Division of Infectious Diseases
Brigham and Women's Hospital
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Joseph J. Eron, MD

Professor of Medicine and Epidemiology
University of North Carolina School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina

Goal Statement
The goal of the symposium is to update clinicians on the latest data on optimal management of patients with second-line ART failure and beyond, and to equip them with practical strategies to select appropriate regimens and optimize outcomes among such patients.

Target Audience
This program is intended for physicians and other healthcare providers who care for patients living with HIV.

Learning Objectives

  • Perform appropriate work-up of patients with virologic failure of two or more antiretroviral regimens, assessing factors contributing to failure and clinical and laboratory parameters relevant to the selection of a new regimen
  • Appraise 2-drug vs 3-drug treatment strategies in the care of persons with HIV infection
  • Describe the mechanisms of action, efficacy, and safety of novel agents with activity against multidrug-resistant HIV in treatment-experienced patients
  • Apply best practices for the design of individualized regimens for treatment-experienced patients


Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation 

CCO designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.